Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Nucleosides & Nucleotides|July 17, 1999
Synthesis of a monocharged peptide nucleic acid (PNA) analog and its recognition as substrate by DNA polymerasesM J Lutz, D W Will, G Breipohl, et al.Agents and Actions. Supplements|January 1, 1992
Metabolism and characterisation of kinins and Hoe 140 (kinin antagonist) in the synovial fluid of patients with inflammatory joint diseasesA P Bond, G Breipohl, K Worthy, et al.European Journal of Pharmacology|January 14, 1992
Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3,Thi5,D-Tic7,Qic8]bradykinin)N E Rhaleb, N Rouissi, D Jukic, et al.The Journal of Biological Chemistry|August 15, 1993
Structural features of the human bradykinin B2 receptor probed by agonists, antagonists, and anti-idiotypic antibodiesS A Alla, J Buschko, U Quitterer, et al.British Journal of Pharmacology|March 1, 1991
Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studiesK Wirth, F J Hock, U Albus, et al.British Journal of Pharmacology|March 1, 1991
Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studiesF J Hock, K Wirth, U Albus, et al.Biochemical and Biophysical Research Communications|April 30, 1992
Inhibition of HIV-1 protease by short peptides derived from the terminal segments of the proteaseH J Schramm, G Breipohl, J Hansen, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2000
RGD mimetics containing a central hydantoin scaffold: alpkha(v)beta3 vs alpha(IIb)beta3 selectivity requirementsA Peyman, V Wehner, J Knolle, et al.Bioorganic & Medicinal Chemistry Letters|July 17, 2001
alpha(v)beta(3) Antagonists based on a central thiophene scaffoldA Peyman, K Scheunemann, D W Will, et al.Pageof 2